ElpasBio Holdings ("ElpasBio"), a leading clinical-stage biotechnology company focused on regenerative medicine, today announced that it has entered into a collaboration agreement with Fosun Kairos ...

ElpasBio Holdings ("ElpasBio"), a leading clinical-stage biotechnology company focused on regenerative medicine, ...

We always relate diabetes to aged people or obese individuals, while scientists have discovered some shocking facts about ...

Professor Idit Maya, a senior physician and manager of the Nephrogenetic Clinic and Genomic School for Physicians at Rabin ...

A new study from the University of Haifa suggests that disorders as different as Alzheimer’s, schizophrenia, and autism may ...

Enhanced chemosensitivity: Laboratory data suggest PRP makes resistant pancreatic tumor cells more responsive to standard chemotherapies and alters the tumor microenvironment — including reduced ...

A mother of two, who once feared she would not live to see her children grow up after a persistent sore throat led to an ...

Detailed price information for Century Therapeutics Inc (IPSC-Q) from The Globe and Mail including charting and trades.

RYTELO® (imetelstat) net product revenue expected in the range of $220 to $240 million2026 total operating expenses expected in the range of ...

Cordlife's cord blood banking licence has been renewed for one year, allowing continued storage and transfer of existing cord ...

In officer-created danger cases, civilians often begin in non-dangerous situations. The danger arises only after aggressive ...